IceCure Medical Announced Adventist Health Glendale Signed Agreement, Received IRB Approval To Become First Clinical Site To Enroll Patients In Post-Marketing ChoICE Study For ProSense In Local Treatment Of Low-Risk Breast Cancer

Loading news article.

IceCure Medical Announced Adventist Health Glendale Signed Agreement, Received IRB Approval To Become First Clinical Site To Enroll Patients In Post-Marketing ChoICE Study For ProSense In Local Treatment Of Low-Risk Breast Cancer | WAPE

IceCure Medical Announced Adventist Health Glendale Signed Agreement, Received IRB Approval To Become First Clinical Site To Enroll Patients In Post-Marketing ChoICE Study For ProSense In Local Treatment Of Low-Risk Breast Cancer

Article summary

Related companies

Comments —